Incidence, prevalence, hospitalization rates and treatment patterns in myasthenia gravis: A 10-year real-world data analysis of German claims data

Conclusion: This is the first study on MG prevalence and incidence rates in Germany. Data shows an increase in prevalence by 1.8-fold over 10 years. Decreasing incidence and hospitalization rates in 2020 hint at the impact of the COVID-19 pandemic. Treatment patterns in MG are changing with the advent of therapeutic monoclonal antibodies in this indication.
Source: Neuroepidemiology - Category: Epidemiology Source Type: research